David R Guay

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. doi Cranberry and urinary tract infections
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Drugs 69:775-807. 2009
  2. pmc Drug forecast - the peptide deformylase inhibitors as antibacterial agents
    David R P Guay
    College of Pharmacy, University of Minnesota and Division of Geriatrics, HealthPartners Inc Minneapolis, MN, USA
    Ther Clin Risk Manag 3:513-25. 2007
  3. doi Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder
    David R P Guay
    Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA
    Consult Pharm 27:857-67. 2012
  4. doi Antimicrobial prophylaxis in noncardiac prosthetic device recipients
    David R Guay
    College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
    Hosp Pract (1995) 40:44-74. 2012
  5. ncbi Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability
    David R P Guay
    Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Consult Pharm 22:1004-34. 2007
  6. ncbi Are there alternatives to the use of quinine to treat nocturnal leg cramps?
    David R Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Consult Pharm 23:141-56. 2008
  7. ncbi Contemporary management of uncomplicated urinary tract infections
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Drugs 68:1169-205. 2008
  8. ncbi Rivastigmine transdermal patch: role in the management of Alzheimer's disease
    David R Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, 308 Harvard Street SE, Minneapolis, MN 55455, USA
    Consult Pharm 23:598-609. 2008
  9. doi Inappropriate sexual behaviors in cognitively impaired older individuals
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Am J Geriatr Pharmacother 6:269-88. 2008
  10. ncbi Drug treatment of paraphilic and nonparaphilic sexual disorders
    David R P Guay
    Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA
    Clin Ther 31:1-31. 2009

Detail Information

Publications36

  1. doi Cranberry and urinary tract infections
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Drugs 69:775-807. 2009
    ..However, in light of the heterogeneity of clinical study designs and the lack of consensus regarding the dosage regimen and formulation to use, cranberry products cannot be recommended for the prophylaxis of recurrent UTIs at this time...
  2. pmc Drug forecast - the peptide deformylase inhibitors as antibacterial agents
    David R P Guay
    College of Pharmacy, University of Minnesota and Division of Geriatrics, HealthPartners Inc Minneapolis, MN, USA
    Ther Clin Risk Manag 3:513-25. 2007
    ..Despite these current liabilities, further pursuit of more potent and broader spectrum PDIs which are less susceptible to bacterial mechanisms of resistance is still warranted...
  3. doi Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder
    David R P Guay
    Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA
    Consult Pharm 27:857-67. 2012
    ..This paper will review the chemistry, pharmacodynamics, pharmacokinetics, clinical efficacy, tolerability, drug-drug interaction potential, dosing, and administration of this agent...
  4. doi Antimicrobial prophylaxis in noncardiac prosthetic device recipients
    David R Guay
    College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
    Hosp Pract (1995) 40:44-74. 2012
    ..However, secondary antimicrobial prophylaxis in recipients of other types of prosthetic devices has been the subject of much controversy, with a wide variety of recommendations being made...
  5. ncbi Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability
    David R P Guay
    Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Consult Pharm 22:1004-34. 2007
    ..To assess the potential role of newer antiepileptic drugs (AEDs) in the management of agitation/aggression in patients with dementia or developmental disability...
  6. ncbi Are there alternatives to the use of quinine to treat nocturnal leg cramps?
    David R Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Consult Pharm 23:141-56. 2008
    ..To review the efficacy and tolerability profiles of quinine in nocturnal and dialysis-associated leg cramps and to examine potential alternative agents...
  7. ncbi Contemporary management of uncomplicated urinary tract infections
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Drugs 68:1169-205. 2008
    ..It can be anticipated that the optimal approach to the management of uUTIs will change substantially in the future as a consequence of antimicrobial resistance...
  8. ncbi Rivastigmine transdermal patch: role in the management of Alzheimer's disease
    David R Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, 308 Harvard Street SE, Minneapolis, MN 55455, USA
    Consult Pharm 23:598-609. 2008
    ..To assess the potential role of a new transdermal (TD) formulation of rivastigmine in the management of Alzheimer's disease...
  9. doi Inappropriate sexual behaviors in cognitively impaired older individuals
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Am J Geriatr Pharmacother 6:269-88. 2008
    ..Substantial mental and physical harm can occur secondary to these behaviors. The common perception is that such behavior cannot be treated...
  10. ncbi Drug treatment of paraphilic and nonparaphilic sexual disorders
    David R P Guay
    Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA
    Clin Ther 31:1-31. 2009
    ..These fantasies, urges, and behaviors produce clinically significant distress or impairments in social, occupational, and other important areas of functioning...
  11. ncbi Methylnaltrexone methobromide: the first peripherally active, centrally inactive opioid receptor-antagonist
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneanpolis, MN 55455, USA
    Consult Pharm 24:210-26. 2009
    ..To review the chemistry, pharmacodynamics, pharmacokinetics, clinical efficacy, tolerability, indications, and dosing and administration of methylnaltrexone methobromide, the first approved peripherally selective opioid receptor-antagonist...
  12. ncbi Is tapentadol an advance on tramadol?
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
    Consult Pharm 24:833-40. 2009
    ....
  13. doi Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Am J Geriatr Pharmacother 8:331-73. 2010
    ..Tetrabenazine (TBZ) is a monoamine-depleting agent initially studied in the 1950s and currently approved by the US Food and Drug Administration for the treatment of chorea in Huntington's disease...
  14. doi Oral hydromorphone extended-release
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Consult Pharm 25:816-28. 2010
    ..To review the chemistry, pharmacodynamics, pharmacokinetics, efficacy, tolerability, dosing, and role of the Osmotic-controlled Release Oral delivery System (OROS) hydromorphone extended-release (ER) tablets...
  15. doi Dabigatran etexilate: a possible replacement for heparinoids and vitamin K antagonists?
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
    Hosp Pract (1995) 39:105-25. 2011
    ..Dabigatran etexilate appears to be a valuable addition to our anticoagulant armamentarium...
  16. ncbi Topical clindamycin in the management of acne vulgaris
    David R P Guay
    University of Minnesota, College of Pharmacy, Department of Experimental and Clinical Pharmacology, Weaver Densford Hall 7 148, 308 Harvard Street SE, Minneapolis, MN, 55455, USA
    Expert Opin Pharmacother 8:2625-64. 2007
    ..e., handwashing between seeing patients in the clinic) can both clindamycin's and erythromycin's widespread utility be preserved in this disorder...
  17. ncbi Update on clindamycin in the management of bacterial, fungal and protozoal infections
    David Guay
    University of Minnesota, College of Pharmacy, Weaver Densford Hall 7 148, 308 Harvard Street SE, Minneapolis, MN 55455, USA
    Expert Opin Pharmacother 8:2401-44. 2007
    ....
  18. ncbi Update on fenofibrate
    David R P Guay
    University of Minnesota, College of Pharmacy, Weaver Densford Hall 7 115C, 308 Harvard Street SE, Minneapolis, MN 55455, USA
    Cardiovasc Drug Rev 20:281-302. 2002
    ..The results of other ongoing outcome trials are eagerly awaited. These results will help to establish the overall place of fenofibrate in the hypolipidemic armamentarium...
  19. ncbi Trandolapril: a newer angiotensin-converting enzyme inhibitor
    David R P Guay
    Institute for the Study of Geriatric Pharmacotherapy, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Clin Ther 25:713-75. 2003
    ..The fixed-dose combination of trandolapril and verapamil extended release (ER) is approved for the treatment of hypertension only...
  20. ncbi Treatment of bacterial skin and skin structure infections
    David R P Guay
    College of Pharmacy, University of Minnesota, Weaver Densford Hall 7 115C, 308 Harvard Street SE, Minneapolis, MN 55455, USA
    Expert Opin Pharmacother 4:1259-75. 2003
    ..Perhaps this assessment will change if the penetrance of the antimicrobial resistance patterns described above reach a critical threshold and clinical failures become more widespread...
  21. ncbi Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain
    David R P Guay
    Department of Experimental and Clinical Pharmacology, Institute for the Study of Geriatric Pharmacotherapy, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    Am J Geriatr Pharmacother 1:18-37. 2003
    ..Based on the experience with carbamazepine, gabapentin, and lamotrigine, these newer AEDs are being investigated for the management of neuropathic pain...
  22. ncbi Extended-release alfuzosin hydrochloride: a new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia
    David R P Guay
    Department of Experimental and Clinical Pharmacology, Institute for the Study of Geriatric Pharmacotherapy, College of Pharmacy, University of Minnesota, MN 55455, USA
    Am J Geriatr Pharmacother 2:14-23. 2004
    ..Although new to the United States, alfuzosin has been available in immediate-release (IR) and sustained-release (SR) formulations in other countries for many years...
  23. ncbi Dalbavancin: an investigational glycopeptide
    David R P Guay
    University of Minnesota, College of Pharmacy, Weaver Densford Hall 7 115C, 308 Harvard Street SE, Minneapolis, MN 55455, USA
    Expert Rev Anti Infect Ther 2:845-52. 2004
    ....
  24. ncbi Duloxetine for management of stress urinary incontinence
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis 55455, USA
    Am J Geriatr Pharmacother 3:25-38. 2005
    ....
  25. ncbi Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis 55455, USA
    Am J Geriatr Pharmacother 3:274-87. 2005
    ..Pregabalin was provisionally approved by the US Food and Drug Administration in December 2004 and was granted final approval after controlled substance scheduling (Schedule V) by the US Drug Enforcement Agency in August 2005...
  26. ncbi Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, 55455, USA
    Pharmacotherapy 26:655-73. 2006
    ..Whether intravenous ibandronate will be a therapeutic advance is best answered by randomized, controlled trials. These are ongoing and should provide data with which to make better-informed choices concerning intravenous bisphosphonates...
  27. ncbi Use of oral oxymorphone in the elderly
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, MN 55455, USA
    Consult Pharm 22:417-30. 2007
    ..To review the pharmacodynamics, pharmacokinetics, efficacy, tolerability, dosing, and role of oral oxymorphone immediate-release (IR) and extended-release (ER)...
  28. ncbi Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Am J Geriatr Pharmacother 4:330-46. 2006
    ....
  29. ncbi Guidelines for the management of adults with health care-associated pneumonia: implications for nursing facility residents
    David R Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Menneapolis, MN 55455, USA
    Consult Pharm 21:719-25. 2006
    ..To review the implications for nursing facility residents of the 2005 American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines for the Management of Adults with Health Care-Associated Pneumonia...
  30. ncbi Pneumococcal polysaccharide revaccination: immunoglobulin g seroconversion, persistence, and safety in frail, chronically ill older subjects
    Thomas E Lackner
    Institute for the Study of Geriatric Pharmacotherapy, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Am Geriatr Soc 51:240-5. 2003
    ..To determine the 1-month postpneumococcal polysaccharide-revaccination immunoglobulin G (IgG) antibody response, its persistence at 1 year, and tolerability of revaccination in frail, chronically ill older nursing facility residents...
  31. ncbi Clinical pharmacokinetics of drugs used to treat urge incontinence
    David R P Guay
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Clin Pharmacokinet 42:1243-85. 2003
    ....
  32. ncbi Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria
    David R P Guay
    Institute for the Study of Geriatric Pharmacotherapy, Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
    Pharmacotherapy 24:58-68. 2004
    ....
  33. ncbi Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin
    David R P Guay
    Institute for the Study of Geriatric Pharmacotherapy, College of Pharmacy, University of Minnesota, Minneapolis 55455, USA
    Clin Ther 24:473-89. 2002
    ....
  34. ncbi Use of antibacterial drugs in community-dwelling older persons
    David R P Guay
    J Am Geriatr Soc 51:1819-21. 2003